Article
Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Jun 2020
González-Díaz A, Càmara J, Ercibengoa M, Cercenado E, Larrosa N, Quesada M D, Fontanals D, Cubero M, Marimón J M, Yuste J, Ardanuy C
Abstract excerpt
OBJECTIVE: An early reduction of adult invasive pneumococcal disease (IPD) was observed after the 13-valent pneumococcal conjugate vaccine (PCV13) introduction for children in Spain. We analysed the epidemiology of adult IPD in the late-PCV13 period. METHODS: This was a prospective multicentre study of adult IPD involving six hospitals. Strains were serotyped, genotyped and studied for antimicrobial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
